NexImmune (United States)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Immunology and Microbiology 23.0×
• Biochemistry, Genetics and Molecular Biology 7.6×
• Medicine 1.8×
• Neuroscience 1.2×

By volume in 2022–2025: CAR-T cell therapy research, Immunotherapy and Immune Responses, Immune Cell Function and Interaction and Cytomegalovirus and herpesvirus research.

1. 1 CAR-T cell therapy research Oncology 1 works
2. 2 Immunotherapy and Immune Responses Immunology 1 works
3. 3 Immune Cell Function and Interaction Immunology 0 works
4. 4 Cytomegalovirus and herpesvirus research Epidemiology 0 works
5. 5 Microbial metabolism and enzyme function Molecular Biology 0 works
6. 6 Virus-based gene therapy research Genetics 0 works
7. 7 Advanced Glycation End Products research Clinical Biochemistry 0 works
8. 8 T-cell and B-cell Immunology Immunology 0 works
9. 9 Endoplasmic Reticulum Stress and Disease Cell Biology 0 works
10. 10 vaccines and immunoinformatics approaches Molecular Biology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 783% higher than in 2013–2017.

• National Institute of Standards and Technology
• Molecular Oncology (United States)
• Scientific Consulting Group
• NIST Center for Neutron Research
• Material Measurement Laboratory
• Center for Nanoscale Science and Technology
• Information Technology Laboratory
• Robotic Research (United States)